News & Events
- July 12, 2018
- July 5, 2018
-
June 22, 2018
2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop
WHAT: 2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop WHEN: June 22, 2018 WHERE: FDA White Oak Campus, Silver Spring, MD CONTENT: This full day workshop is sponsored by the FDA Oncology Center of Excellence and will consist of four panels made up of international regulatory, payer, academic, patient, industry and policy leaders. Initial agenda planning is... -
June 6, 2018
Third Annual CPP Member Meeting 2018
The third annual CPP Member Meeting (June 6-7, 2018 in London, UK) provided a face-to-face forum for industry, regulators, academic experts and advocacy organizations to collaborate towards the development of Parkinson’s disease therapies. This meeting provided a unique opportunity for stakeholders to celebrate the successes of the consortium to date and align on future options... -
June 1, 2018
Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero M, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O’Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop. Value in Health 2018;21:742-747.